DATE: July 13, 2010
TIME: 2:00 PM
LENGTH: 30 minutes
Did you know that FDA’s review of vaccine safety doesn’t stop once a vaccine is approved? Why is it important to have different types of systems to perform safety surveillance for approved vaccines?
On Tuesday, July 13th, FDA hosted a webinar about the agency’s work to ensure the safety of vaccines. Andrea Sutherland, MD, MPH, Msc, who is a medical officer and Special Assistant to the Director of the Division of Epidemiology in the Office of Biostatistics and Epidemiology in FDA’s Center for Biologics Evaluation and Research, provided an overview and answered questions about vaccine safety surveillance, including the Vaccine Adverse Event Reporting System (or VAERS), and efforts underway to improve safety monitoring. Currently, FDA is working with federal, international, academic, and health care partners to further improve its ability to evaluate the safety of vaccines throughout the lifecycle of products.
- FDA Webinar on Protecting Your Child's Health Through Safe and Effective Vaccines
- FDA Webinar on Safety of the Blood Supply
- What are stem cells? How are they regulated?
- What is a biological product?
- Webinar on FDA’s Safety Monitoring of Approved Vaccines
- What is thimerosal? Is it safe when used in some vaccines?
- How can I get my name removed from a donor deferral list?
- How does FDA regulate tissue products? What safeguards are in place for recipients?
- How do I know if I’m eligible to donate blood?
- What is the Vaccine Adverse Event Reporting System (VAERS)?
- What is the approval process for a biological product?
- How do I report an adverse event related to a vaccine?
- How does FDA assess the safety of vaccines?